Arabic Arabic English English French French German German
dark

Public Meeting on Patient Focused Drug Development for People Who Received an Organ Transplant Pt. 4

On September 27, 2016, FDA hosted a public meeting on Patient-Focused Drug Development for Patients Who Received an Organ Transplant. FDA was interested in obtaining patient perspectives on the impact of receiving an organ transplant on daily life and patient views on treatment approaches. For more information, visit https://go.usa.gov/xHbhX.

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Jazan: 610 Cardiac Catheterizations Performed by Prince Muhammed bin Nasser Hospital in 3 Months

Next Post

WHO and the International Organisation of the Francophonie (IOF) sign Memorandum of Understanding to strengthen access to health in Francophone countries

Related Posts
Total
0
Share